You are here
AusPAR: Crizanlizumab
Related information
Australian Public Assessment Report
24 August 2021
| AusPAR | |
|---|---|
| Active Ingredient | Crizanlizumab
|
| Product Name | Adakveo
|
| Sponsor | Novartis Pharmaceuticals Australia Pty Ltd
|
| Submission Number | PM-2019-05705-1-6
|
| Submission Type | New biological entity
|
| Decision | Approved
|
| AusPAR Date | 16 July 2021
|
| Publication Date | 24 August 2021 |